search
Back to results

Does Cricoid Pressure Reduce the Risk of Aspiration?

Primary Purpose

Microaspiration, Acute Respiratory Distress Syndrome (ARDS), Hospital Acquired Pneumonia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cricoid pressure
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Microaspiration focused on measuring Microaspiration, ARDS, Hospital acquired pneumonia, Cricoid pressure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

  • Obesity (BMI>30)
  • Diabetes mellitus
  • Gastroesophageal reflux disease (GERD)
  • schedule cardiac, aortic vascular or non-cardiac thoracic procedure

Exclusion criteria:

  • emergent surgery
  • risk factors for macroaspiration (non-fasting status, bowel obstruction, achalasia, hiatal hernia, esophageal stricture, esophageal diverticulum), altered level of consciousness, known pregnancy
  • preoperative ARDS
  • preoperative pneumonia

Sites / Locations

  • Mayo Clinic - Saint Mary's Campus
  • Mayo Clinic in Rochester

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Cricoid pressure

No cricoid pressure

Arm Description

Patients randomized to receive cricoid pressure during endotracheal intubation.

Patients randomized to receive no cricoid pressure during endotracheal intubation.

Outcomes

Primary Outcome Measures

Rate of microaspiration
Tracheal secretions will be collected and later analyzed for the presence of pepsin A.

Secondary Outcome Measures

Rate of ARDS

Full Information

First Posted
January 26, 2014
Last Updated
December 30, 2015
Sponsor
Mayo Clinic
Collaborators
Alfred I. duPont Hospital for Children
search

1. Study Identification

Unique Protocol Identification Number
NCT02058004
Brief Title
Does Cricoid Pressure Reduce the Risk of Aspiration?
Official Title
Does Cricoid Pressure Reduce the Risk of Aspiration?
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
August 2014 (undefined)
Primary Completion Date
October 2014 (Actual)
Study Completion Date
October 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
Collaborators
Alfred I. duPont Hospital for Children

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In modern anesthesia practice, the application of cricoid pressure during intubation is not infrequently used with the goal of preventing gastric-to-pulmonary aspiration. The evidence to support this practice is very scarce, and there have recently been many reports in the literature questioning the safety of cricoid pressure during intubation. Therefore, the goal of this study will be to randomize those at risk for microaspiration to receive cricoid pressure versus no cricoid pressure during intubation. We will specifically exclude those patients thought to be at the highest risk of aspiration (it is considered standard of care to perform cricoid pressure during intubation of this population). We will include those patients with some risk factors for aspiration (it is not considered standard of care to apply cricoid pressure during intubation of this population).
Detailed Description
Gastric-to-pulmonary aspiration during induction of anesthesia remains a significant risk in the modern practice of anesthesia.(1) Macroaspiration (grossly visible aspiration) has been clearly associated with severe pulmonary injury.(1-4) More recently, microaspiration (aspiration without grossly visible gastric material) has also been associated with significant morbidity.(2) Specifically, microaspiration has been associated with acute respiratory distress syndrome (ARDS)(5), ventilator associated pneumonia (VAP)(6) and acute respiratory failure due to bronchoconstriction and ventilation-perfusion mismatching. Pepsin A has been shown to be a very specific biochemical marker for gastric-to-pulmonary aspiration.(7) In our previous studies, we demonstrated the rate of microaspiration in normal elective surgical patients without risk factors for aspiration was 4% as detected by the ELISA assay for pepsin A.(8) This compared with a rate of 12.5% in patients with risk factors for microaspiration including obesity, GERD (gastroesophageal reflux disease) and diabetes. One proposed technique to prevent gastric-to-pulmonary aspiration is cricoid pressure. Recently, there has been growing evidence which calls into question the effectiveness of cricoid pressure. Radiologic studies by Smith et al yield indirect evidence to suggest that cricoid pressure may not reliably occlude the esophagus.(9,10) Currently, cricoid pressure for patients with risk factors for microaspiration (obesity, GERD and diabetes) is used commonly but inconsistently.(11) By using the same sampling and analysis techniques employed in our previous microaspiration studies, the currently proposed study will provide a very sensitive and specific assessment of the effectiveness of cricoid pressure to prevent aspiration during elective induction of anesthesia and intubation. Our proposed study would enroll patients with risk factors for microaspiration who are scheduled to undergo high-risk (for pulmonary complications) elective surgery requiring endotracheal intubation. We will exclude those with risk factors for macroaspiration (including bowel obstruction, non-fasting status and esophageal pathology associated with increased risk for macroaspiration such as achalasia and hiatal hernia), because cricoid pressure remains the standard of care for those at risk for macroaspiration at our institution. Those patients enrolled will be randomized to receive cricoid pressure versus no cricoid pressure. Immediately following elective intubation, a sample of tracheal secretions from each patient will be obtained and the pepsin A concentration determined. The primary outcome will be the rate of microaspiration determined by the presence of pepsin A in the trachea. Secondary outcomes of interest will be rates of postoperative pulmonary complications including acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP). The findings of this study will provide the most direct evidence yet regarding the effectiveness of cricoid pressure for the prevention of gastric-to-pulmonary aspiration during induction of anesthesia and endotracheal intubation. Ultimately, the findings of this study will improve patient safety by providing accurate prospective evidence regarding the effectiveness and safety of cricoid pressure in this setting, and will further explore the clinical significance of microaspiration.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Microaspiration, Acute Respiratory Distress Syndrome (ARDS), Hospital Acquired Pneumonia
Keywords
Microaspiration, ARDS, Hospital acquired pneumonia, Cricoid pressure

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
95 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cricoid pressure
Arm Type
Experimental
Arm Description
Patients randomized to receive cricoid pressure during endotracheal intubation.
Arm Title
No cricoid pressure
Arm Type
No Intervention
Arm Description
Patients randomized to receive no cricoid pressure during endotracheal intubation.
Intervention Type
Procedure
Intervention Name(s)
Cricoid pressure
Intervention Description
Firm pressure on the cricoid cartilage with the goal of occluding the esophagus during endotracheal intubation.
Primary Outcome Measure Information:
Title
Rate of microaspiration
Description
Tracheal secretions will be collected and later analyzed for the presence of pepsin A.
Time Frame
Within 15 minutes of intubation
Secondary Outcome Measure Information:
Title
Rate of ARDS
Time Frame
Within 7 days of intubation
Other Pre-specified Outcome Measures:
Title
Rate of hospital acquired pneumonia
Time Frame
Within 7 days of intubation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: Obesity (BMI>30) Diabetes mellitus Gastroesophageal reflux disease (GERD) schedule cardiac, aortic vascular or non-cardiac thoracic procedure Exclusion criteria: emergent surgery risk factors for macroaspiration (non-fasting status, bowel obstruction, achalasia, hiatal hernia, esophageal stricture, esophageal diverticulum), altered level of consciousness, known pregnancy preoperative ARDS preoperative pneumonia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Bohman, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic - Saint Mary's Campus
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Facility Name
Mayo Clinic in Rochester
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Does Cricoid Pressure Reduce the Risk of Aspiration?

We'll reach out to this number within 24 hrs